Emory University: Breast Neoplasms trials

The registry lists 33 Breast Neoplasms studies with Emory University as lead sponsor. 4 are open to participants now and 17 have results posted.

Phase 1 6Phase 2 14No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in KenyaRecruitingNCT07764796Not applicable
• Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health ClinicsRecruitingNCT06760507Not applicable
• Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast CancerRecruitingNCT06324240Phase 1
• Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With PembrolizumabRecruitingNCT05877859
• Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast CancerCompletedNCT04750473Phase 1Results posted
• Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone MetastasisCompletedNCT03691493Phase 2Results posted
• THRIVE Breast Cancer App StudyCompletedNCT03592771Not applicableResults posted
• Hypofractionated Radiotherapy in Breast CancerCompletedNCT03167359Not applicableResults posted
• To Enhance Breast Cancer Survivorship of Asian AmericansCompletedNCT02803593Not applicableResults posted
• Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerTerminatedNCT02273752Phase 2Results posted
• Phase II Study of Everolimus Beyond ProgressionTerminatedNCT02269670Phase 2Results posted
• Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast CancerTerminatedNCT01498588Phase 2Results posted
• A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast CancerTerminatedNCT01272141Phase 2Results posted
• Re-expression of ER in Triple Negative Breast CancersTerminatedNCT01194908Phase 1/2Results posted
• Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast CancerTerminatedNCT01194869Phase 2Results posted
• Exemestane or Docetaxel-Cytoxan in Low Recurrence Score CancersCompletedNCT00941330Phase 2Results posted
• Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast CancerCompletedNCT00912340Phase 2Results posted
• Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence ScoresTerminatedNCT00832338Phase 2Results posted
• A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast CancerTerminatedNCT00674206Phase 2Results posted
• Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)CompletedNCT00503750Phase 2Results posted
• Randomized Phase II Trial Induction Therapy for Early Stage Breast CancerCompletedNCT00209092Phase 2Results posted
• A Patient Reminder and Self-Referral Via Online Patient Portals and Text Messaging to Improve Adherence to Breast Cancer ScreeningCompletedNCT05526872Not applicable
• Radioembolization of Metastatic Breast Cancer to the Liver as a 2nd/3rd Line TherapyWithdrawnNCT05315687Phase 2
• Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast CancerCompletedNCT05086731Not applicable
• Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain MetastasesWithdrawnNCT04585724Phase 1
• Palbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsCompletedNCT02897375Phase 1
• Fatigue in Breast Cancer Patients Undergoing Radiotherapy-eSMART-MHWithdrawnNCT02759549Not applicable
• Inflammation-Induced CNS Glutamate During Breast Cancer TreatmentCompletedNCT02421978
• Evaluation of Magnetic Resonance Imaging (MRI) vs Molecular Breast Imaging (Tc-MBI) in Breast Cancer PatientsTerminatedNCT02024074Phase 1
• Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast CancerCompletedNCT01271738Not applicable
• Chemotherapy Monitoring With Breast Computed Tomography (CT)CompletedNCT00808041
• Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast CancerTerminatedNCT00209001Not applicable
• An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of RecallCompletedNCT00208871Not applicable